Clinical Report: Global Perspectives on Primary Immunodeficiencies, Volume III

Overview

This editorial summarizes key findings from Volume III of the 'Community Series in Primary Immunodeficiencies Worldwide,' highlighting advancements in understanding primary immunodeficiencies (PIDs) and their diagnostic approaches.

Background

Primary immunodeficiencies (PIDs) are rare disorders that lead to increased susceptibility to infections and immune dysregulation. With over 500 identified diseases, understanding PIDs is crucial for improving diagnosis and treatment strategies. Recent advancements in genetic testing and screening programs are enhancing the identification and management of these conditions.

Data Highlights

Key Findings

• Autoimmune symptoms may precede infections in PIDs, serving as early indicators.
• Newborn screening in Ukraine identified 18 cases of PID/IEI from 398,415 screened newborns.
• Hereditary angioedema (HAE) prevalence and treatment access were investigated in the Baltic states.
• LRBA deficiency and MAGT1 deficiency were highlighted as conditions requiring early genetic diagnosis for targeted therapies.
• GATA2 deficiency presents with diverse clinical manifestations, complicating early diagnosis.

Clinical Implications

Recognition of autoimmune symptoms as potential indicators of PIDs can facilitate earlier diagnosis and intervention. Enhanced screening programs and genetic testing are essential for improving patient outcomes in PID management.

Conclusion

The editorial underscores the evolving understanding of primary immunodeficiencies and the critical role of early diagnosis and tailored treatment approaches in improving patient care.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Inborn errors of immunity: a structured model for paediatric-to-adult transition of care
2. Frontiers in Pediatrics, 2026 -- Editorial: Rethinking infection in pediatric atopic dermatitis: from microbial dysbiosis to precision prevention
3. Frontiers in Immunology, 2026 -- Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III
4. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee - PMC
5. Frontiers in Medicine — Bridging the immunology gap in sub-Saharan Africa
6. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee - PMC
7. The 2024 update of IUIS phenotypic classification of human inborn errors of immunity - PMC
8. Inborn errors of immunity: Manifestation, treatment, and outcome—an ESID registry 1994–2024 report on 30,628 patients - PMC
9. 2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical Immunology Society (CIS) - PubMed
10. 2025 Inborn Errors of Immunity Practice Parameters
11. Inborn Errors of Immunity - The EBMT Handbook - NCBI Bookshelf
12. Hematopoietic cell transplantation for inborn errors of immunity: an update on approaches, outcomes and innovations - PubMed
13. Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study - ScienceDirect
14. Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency | New England Journal of Medicine
15. Immunoglobulin replacement therapy in primary immunodeficiency disorders: Pragmatic review and evidence mapping - PMC
16. Frontiers | Immunoglobulin replacement therapies in inborn errors of immunity: a review
17. Newborn Screening Followed By Early Treatment is Essential to Improve Survival in SCID | Journal of Clinical Immunology | Springer Nature Link